Corcept Therapeutics · 3 days ago
Corporate Communications Intern
Corcept Therapeutics is a leading biotech company focused on cortisol modulation and its applications in treating serious diseases. The Corporate Communications Intern will assist in developing communication strategies and support various initiatives to effectively convey the company's vision and progress.
BiotechnologyMedicalPharmaceutical
Responsibilities
Help develop the communications strategies and plans to articulate who Corcept is and why its work is meaningful across external and internal audiences
Support work to communicate Corcept’s vision and scientific progress across all therapeutic areas and appropriate channels through storytelling, targeted messaging and creative campaigns
Contribute to social media editorial calendar creation and tactical execution and ensure overall alignment with division strategy and goals
Play a key role in brand communications projects, including website content, social media content and design
Work with our public relations agency to help bring key initiatives to life
Manage internal employee communications by working to improve the functionality, relevance and offering of CenterCORT (intranet), TV screens, events and researching/developing new tactics in internal communications
Deliver a department presentation at the end of the program
Participate as a member of the 2026 intern team group project that includes a company-wide presentation
Qualification
Required
Must be able to complete at least 10 consecutive weeks between June and August and it is a full-time internship (40 hours per week)
Must be able to work at our Redwood City office for the duration of the internship, no relocation available
Applicants must be currently authorized to work in the United States on a full-time basis
Preferred
Knowledgeable in Microsoft Word, Outlook, PowerPoint, Excel, Social Media sites preferred
Experience and interest in communications, public relations and/or journalism preferred
Excellent verbal and written communication skills
Ability to drive results autonomously and with limited guidance
Company
Corcept Therapeutics
Corcept Therapeutics discovers and develops drugs that regulate the effects of cortisol.
Funding
Current Stage
Public CompanyTotal Funding
$119.09MKey Investors
Paperboy Ventures
2012-07-02IPO
2012-04-10Post Ipo Equity· $0.53M
2011-01-21Post Ipo Equity· $39M
Recent News
Genetic Engineering News
2026-01-05
2026-01-03
Company data provided by crunchbase